Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2025 23:58 ET | Source: 23andMe, Inc.; Troper Wojcicki Philanthropies, Lifebit

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de...
September 06, 2025 11:00 ET | Source: 23andMe Research Institute; Troper Wojcicki Philanthropies, Lifebit

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

Secure access to one of the most diverse lung cancer genetics cohorts ever assembled is now available for FREE to qualified researchers.
July 14, 2025 10:10 ET | Source: 23andMe, Inc.

TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced...
June 30, 2025 08:00 ET | Source: 23andMe, Inc.

23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received...
June 13, 2025 16:22 ET | Source: 23andMe, Inc.

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

TTAM Commits to Comply with Company’s Privacy Policy and All Applicable LawsTTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer...
May 27, 2025 12:45 ET | Source: 23andMe, Inc.

23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to...
May 19, 2025 07:04 ET | Source: 23andMe, Inc.

Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome ServicesTransaction Subject to Court Approval SAN FRANCISCO,...
April 18, 2025 16:30 ET | Source: 23andMe, Inc.

23andMe Provides Update Regarding Court-Supervised Sale Process

SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today provided additional...
March 26, 2025 18:57 ET | Source: 23andMe, Inc.

23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law

SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has...
March 23, 2025 23:08 ET | Source: 23andMe, Inc.

23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process

Intends to use Proceedings to Conduct a Value-Maximizing Sale Process and Resolve Liabilities Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures...